摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-methyl-4-oxo-4,5-dihydro-pyrrolo[1,2-a]quinoxaline-2-carboxylic acid ethyl ester | 69015-14-1

中文名称
——
中文别名
——
英文名称
5-methyl-4-oxo-4,5-dihydro-pyrrolo[1,2-a]quinoxaline-2-carboxylic acid ethyl ester
英文别名
ethyl 5-methyl-4,5-dihydro-4-oxo-pyrrolo[1,2-a]quinoxaline-2-carboxylate;ethyl 5-methyl-4-oxopyrrolo[1,2-a]quinoxaline-2-carboxylate
5-methyl-4-oxo-4,5-dihydro-pyrrolo[1,2-<i>a</i>]quinoxaline-2-carboxylic acid ethyl ester化学式
CAS
69015-14-1
化学式
C15H14N2O3
mdl
——
分子量
270.288
InChiKey
PZWQSMRYBZVRPV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    51.5
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-methyl-4-oxo-4,5-dihydro-pyrrolo[1,2-a]quinoxaline-2-carboxylic acid ethyl estersodium hydroxide 作用下, 以 乙醇 为溶剂, 以95%的产率得到5-methyl-4-oxo-4,5-dihydro-pyrrolo[1,2-a]quinoxaline-2-carboxylic acid
    参考文献:
    名称:
    Pyrroloquinoxalines
    摘要:
    该专利描述了一种新型吡咯喹喔啉类化合物,化学结构如下:其中X和Y分别选自氢、卤素、1至5个碳原子的烷基和烷氧基以及--NO.sub.2的组合,Z选自1至8个碳原子的烷基、3至8个碳原子的环烷基、2至6个碳原子的烯基和苯基,R选自氢、1至5个碳原子的烷基、以及非毒性、药学上可接受的阳离子,n是1至6的整数,R.sub.1和R.sub.2分别为1至5个碳原子的烷基,以及具有抗过敏活性的非毒性、药学上可接受的酸盐,以及其制备的新方法。
    公开号:
    US04151280A1
  • 作为产物:
    参考文献:
    名称:
    Synthesis and oral antiallergic activity of carboxylic acids derived from imidazo[2,1-c][1,4]benzoxazines, imidazo[1,2-a]quinolines, imidazo[1,2-a]quinoxalines, imidazo[1,2-a]quinoxalinones, pyrrolo[1,2-a]quinoxalinones, pyrrolo[2,3-a]quinoxalinones, and imidazo[2,1-b]benzothiazoles
    摘要:
    4H-Imidazo[2,1-c][1,4]benzoxazine-2-carboxylic acid (3) was found to possess potent activity in the IgE-induced rat passive cutaneous anaphylaxis model which may be predictive of clinical antiallergic activity. Compared to disodium cromoglycate (DSCG, 1), 3 was less active following iv administration but unlike DSCG showed very significant oral activity. To explore the structural requirements for this activity, a range of tricyclic compounds was prepared and their activities were measured. Individual 2-carboxylic acids derived from imidazo[1,2-a]quinolines, imidazo[1,2-a]quinoxalines, imidazo[1,2-a]quinoxalinones, pyrrolo[1,2-a]quinoxalinones, pyrrolo[2,3-a]quinoxalinones, and imidazo[2,1-b]benzothiazoles showed iv activities up to 10(3) times as potent as DSCG and many of them showed significant oral activity. From these, imidazo[1,2-a]quinoxaline-2-carboxylic acid 114 has been chosen for further development.
    DOI:
    10.1021/jm00401a009
点击查看最新优质反应信息

文献信息

  • Pyrroloquinoxalines
    申请人:Roussel Uclaf
    公开号:US04151280A1
    公开(公告)日:1979-04-24
    Novel pyrroloquinoxalines of the formula ##STR1## wherein X and Y are individually selected from the group consisting of hydrogen, halogen, alkyl and alkoxy of 1 to 5 carbon atoms and --NO.sub.2, Z is selected from the group consisting of alkyl of 1 to 8 carbon atoms, cycloalkyl of 3 to 8 carbon atoms, alkenyl of 2 to 6 carbon atoms and phenyl and R is selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms, ##STR2## and non-toxic, pharmaceutically acceptable cations, n is an integer from 1 to 6 and R.sub.1 and R.sub.2 are individually alkyl of 1 to 5 carbon atoms and the non-toxic, pharmaceutically acceptable acid addition salts thereof having antiallergic activity and to a novel process for their preparation.
    该专利描述了一种新型吡咯喹喔啉类化合物,化学结构如下:其中X和Y分别选自氢、卤素、1至5个碳原子的烷基和烷氧基以及--NO.sub.2的组合,Z选自1至8个碳原子的烷基、3至8个碳原子的环烷基、2至6个碳原子的烯基和苯基,R选自氢、1至5个碳原子的烷基、以及非毒性、药学上可接受的阳离子,n是1至6的整数,R.sub.1和R.sub.2分别为1至5个碳原子的烷基,以及具有抗过敏活性的非毒性、药学上可接受的酸盐,以及其制备的新方法。
  • AGER, IAN R.;BARNES, ALAN C.;DANSWAN, GEOFFREY W.;HAIRSINE, PETER W.;KAY,+, J. MED. CHEM., 31,(1988) N 6, 1098-1115
    作者:AGER, IAN R.、BARNES, ALAN C.、DANSWAN, GEOFFREY W.、HAIRSINE, PETER W.、KAY,+
    DOI:——
    日期:——
  • US4151280A
    申请人:——
    公开号:US4151280A
    公开(公告)日:1979-04-24
  • Synthesis and oral antiallergic activity of carboxylic acids derived from imidazo[2,1-c][1,4]benzoxazines, imidazo[1,2-a]quinolines, imidazo[1,2-a]quinoxalines, imidazo[1,2-a]quinoxalinones, pyrrolo[1,2-a]quinoxalinones, pyrrolo[2,3-a]quinoxalinones, and imidazo[2,1-b]benzothiazoles
    作者:Ian R. Ager、Alan C. Barnes、Geoffrey W. Danswan、Peter W. Hairsine、David P. Kay、Peter D. Kennewell、Saroop S. Matharu、Peter Miller、Peter Robson
    DOI:10.1021/jm00401a009
    日期:1988.6
    4H-Imidazo[2,1-c][1,4]benzoxazine-2-carboxylic acid (3) was found to possess potent activity in the IgE-induced rat passive cutaneous anaphylaxis model which may be predictive of clinical antiallergic activity. Compared to disodium cromoglycate (DSCG, 1), 3 was less active following iv administration but unlike DSCG showed very significant oral activity. To explore the structural requirements for this activity, a range of tricyclic compounds was prepared and their activities were measured. Individual 2-carboxylic acids derived from imidazo[1,2-a]quinolines, imidazo[1,2-a]quinoxalines, imidazo[1,2-a]quinoxalinones, pyrrolo[1,2-a]quinoxalinones, pyrrolo[2,3-a]quinoxalinones, and imidazo[2,1-b]benzothiazoles showed iv activities up to 10(3) times as potent as DSCG and many of them showed significant oral activity. From these, imidazo[1,2-a]quinoxaline-2-carboxylic acid 114 has been chosen for further development.
查看更多